Efficacy of the Digital Therapeutic OXD01 (MODIA™) for Opioid-use Disorder
This study is completed in the United States. It is testing Efficacy of the Digital Therapeutic OXD01 (MODIA™) for Opioid-use Disorder.
Addiction, Opioid-use DisorderBehavioralFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether a digital tool or app may be useful for adults experiencing addiction.
What would participation involve?
Participants may use a digital tool or app, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with addiction.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: June 30, 2021
Recruitment status
Completed
Enrollment listed in the registry
437
Sponsor
Orexo AB
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
DEVICE, OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04948307
Official title
A Randomized, Open-label, Parallel-group Study to Evaluate the Efficacy of the Digital Therapeutic OXD01 (MODIA™) in Combination With Sublingual Buprenorphine/Naloxone for the Treatment of Opioid Use Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04948307. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 21 sites
Parkway Medical Center
Birmingham, Alabama
Site status: Not listed — confirm with the team
North County Clinical Research
Oceanside, California
Site status: Not listed — confirm with the team
Artemis Institute for Clinical Research
San Diego, California
Site status: Not listed — confirm with the team
Wetlin Research Associates, Inc
San Diego, California
Site status: Not listed — confirm with the team
Humanity Clinical Research
Pembroke Pines, Florida
Site status: Not listed — confirm with the team
Southern Illinois Associates LLC
Glen Carbon, Illinois
Site status: Not listed — confirm with the team
Otrimed Clinical Research
Edgewood, Kentucky
Site status: Not listed — confirm with the team
Patient First Medical Clinic
Dearborn, Michigan
Site status: Not listed — confirm with the team
Precise Research Centers
Flowood, Mississippi
Site status: Not listed — confirm with the team
PsychCare Consultants Research
St Louis, Missouri
Site status: Not listed — confirm with the team
Dr. Vando Medical Services PC
The Bronx, New York
Site status: Not listed — confirm with the team
Midwest Clinical Research Center
Dayton, Ohio
Site status: Not listed — confirm with the team
North Star Medical Research
Middleburg Heights, Ohio
Site status: Not listed — confirm with the team
Neuro-Behavioral Clinical Research Center
North Canton, Ohio
Site status: Not listed — confirm with the team
CincyScience
West Chester, Ohio
Site status: Not listed — confirm with the team
Pahl Pharmaceuticals Professions
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Thalia Medical Center
Haverford, Pennsylvania
Site status: Not listed — confirm with the team
MD Medical Management
Kingston, Pennsylvania
Site status: Not listed — confirm with the team
Medically Assisted Recovery Service
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Institute of Addiction Medicine
Plymouth Meeting, Pennsylvania
Site status: Not listed — confirm with the team
Aspen Clinical Research
Orem, Utah
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring digital app or tool for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving OXD01 digital therapy, Standard of Care. Phase is mainly useful to check for medication studies and some device studies.
Are there criteria about substance use or wanting to reduce it?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Orexo AB, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
